Viamet Announces Awarding of Department of Defense Grant

Viamet Pharmaceuticals today announced the awarding of a $2.0 million grant from the Department of Defense focused on the development of a novel topical antifungal agent to prevent and treat mold infections as a result of battlefield wounds. The grant is intended to fund research and development activities over the next three years.